The trade-off is that it is harder to measure with a regular syringe
Behavioral testing
The American Diabetes Association Standards of Care acknowledges these gastrointestinal effects and recommends gradual dose titration as a key strategy to improve tolerability of GLP-1 receptor agonists
Dunn WB, Broadhurst D, Begley P, Zelena E, Francis-McIntyre S, Anderson N, et al
No Disease Claims: This compound is not intended to diagnose, treat, cure, or prevent any disease
The primary mechanisms of action include: Enhancing insulin secretion from the pancreas in response to elevated blood glucose levels, which helps lower blood sugar Suppressing glucagon release , a hormone that raises blood glucose Slowing gastric emptying , which means food moves more slowly from the stomach into the small intestine Reducing appetite through effects on brain centres that regulate hunger and satiety These combined effects make GLP-1 receptor agonists effective for glycaemic control in type 2 diabetes and, for those specifically licensed for weight management, achieving significant weight loss
